Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells in Patients After Stroke


Phase 1/2 Results N/A

Summary of Purpose

The intent of this clinical study is to answer the questions: 1. Is the proposed treatment safe 2. Is treatment effective in improving the disease pathology of patients after Stroke and clinical outcomes? Trial Stopped: no enrolled participants

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 19 July 2017.

1 Oct 2014 3 Oct 2011 1 Dec 2014 1 Jun 2015 1 Jul 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Non-Randomized
  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Single Group Assignment